Literature DB >> 9232276

MRI in patients with axillary metastases of occult breast carcinoma.

M M Tilanus-Linthorst1, A I Obdeijn, M Bontenbal, M Oudkerk.   

Abstract

In 4 women with adenocarcinoma metastasis in an axillary lymph node and no primary tumor found, we investigated whether Magnetic Resonance Imaging (MRI) of the breast could detect a clinically and mammographically occult breast tumor. MRI detected an enhancing lesion in 3 women and an enhancing double lesion in one patient. MRI directed ultrasound guided fine needle aspiration cytology confirmed the 5 breast carcinomas in the 4 women. In women with metastasis in an axillary lymph node consistent with breast cancer and without a primary tumor, MRI of the breast should added to clinical examination and mammography before defining it as an occult primary and planning therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9232276     DOI: 10.1023/a:1005774009740

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

Review 1.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

2.  Skin involvement and breast cancer: are T4b lesions of all sizes created equal?

Authors:  Diana Silverman; Karen Ruth; Elin R Sigurdson; Brian L Egleston; Lori J Goldstein; Yu-Ning Wong; Marcia Boraas; Richard J Bleicher
Journal:  J Am Coll Surg       Date:  2014-04-20       Impact factor: 6.113

Review 3.  'Occult' breast cancer.

Authors:  M S Lloyd; A G Nash
Journal:  Ann R Coll Surg Engl       Date:  2001-11       Impact factor: 1.891

4.  Evaluation of Real-world Data for Breast-MRI BI-RADS IV Lesions.

Authors:  Jens Hachenberg; Christian Eichler; Lena Steinkasserer; Wolfram Malter; Fabinshy Thangarajah; Mathias Warm; Axel Gossmann; Markus Brod; Caroline Pahmeyer
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

5.  Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy.

Authors:  Katrien Schelfout; E Kersschot; M Van Goethem; L Thienpont; J Van den Haute; A Roelstraete; A De Schepper
Journal:  Eur Radiol       Date:  2002-11-19       Impact factor: 5.315

6.  Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.

Authors:  A Piga; R Nortilli; G L Cetto; N Cardarelli; S Luzi Fedeli; G Fiorentini; M D'Aprile; F Giorgi; A P Parziale; A Contu; R Montironi; R Gesuita; F Carle; R Cellerino
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.